As of 2026-03-14, the Fair Value of Bright Minds Biosciences Inc (DRUG.CN) is -10.20 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 97.83 CAD, the upside of Bright Minds Biosciences Inc is -110.42%.
With the market price of 97.83 CAD and our fair value calculation, Bright Minds Biosciences Inc (DRUG.CN) is not a good investment. Investing in DRUG.CN stocks now will result in a potential loss of 110.42%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 5Y Avg | |
| Net income | -8.65 | -14.96 | -7.37 | -2.80 | -12.23 | -9.20 |
| YoY growth | -1,700.82% | -72.99% | 50.74% | 61.99% | -336.46% | -399.51% |
| Market Cap (mil) | 951.89 |
| P/E | |
| Forward P/E |
| EPS | -2.04 |
| Avg earnings growth rate | -399.51% |
| TTM earnings | -19.84 |